falsefalse

Clinical Advances in Nasopharyngeal Carcinoma - Episode 3

Overview of the JUPITER and POLARIS-2 Trials

, ,

Victoria M. Villaflor, MD, provides insights on the role of immune checkpoint inhibitors in treating nasopharyngeal carcinoma, focusing on the JUPITER and POLARIS-2 clinical trials.

Video Player is loading.
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected

    Video content above is prompted by the following:

    • Have you had clinical experience with immune checkpoint inhibitors in combination with chemotherapy for your patients with NPC?
    • Please give your thoughts on the JUPITER and POLARIS-2 trials in NPC.
    x